Overview

A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia

Status:
RECRUITING

Trial end date:
2029-08-23

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of KarXT in acutely psychotic Japanese adult participants with schizophrenia

Phase:

PHASE3

Details

Lead Sponsor:

Bristol-Myers Squibb